Payer Perspective of the American Academy of Sleep Medicine Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia
- PMID: 28095976
- PMCID: PMC5263066
- DOI: 10.5664/jcsm.6428
Payer Perspective of the American Academy of Sleep Medicine Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia
Similar articles
-
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.J Clin Sleep Med. 2017 Feb 15;13(2):307-349. doi: 10.5664/jcsm.6470. J Clin Sleep Med. 2017. PMID: 27998379 Free PMC article.
-
Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.Curr Med Res Opin. 2007 Jun;23(6):1431-43. doi: 10.1185/030079907X199619. Epub 2007 May 17. Curr Med Res Opin. 2007. PMID: 17559740
-
The direct economic costs of insomnia in the United States for 1995.Sleep. 1999 May 1;22 Suppl 2:S386-93. Sleep. 1999. PMID: 10394612
-
The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary.J Clin Sleep Med. 2005 Jan 15;1(1):49-59. J Clin Sleep Med. 2005. PMID: 17561616
-
Endorsement of European guideline for the diagnosis and treatment of insomnia by the World Sleep Society.Sleep Med. 2021 May;81:124-126. doi: 10.1016/j.sleep.2021.01.023. Epub 2021 Jan 21. Sleep Med. 2021. PMID: 33667998 Review.
Cited by
-
Factors Associated with Insomnia Among Truck Drivers in Japan.Nat Sci Sleep. 2021 May 18;13:613-623. doi: 10.2147/NSS.S307904. eCollection 2021. Nat Sci Sleep. 2021. PMID: 34040470 Free PMC article.
-
Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia.Front Aging Neurosci. 2020 Jan 8;11:344. doi: 10.3389/fnagi.2019.00344. eCollection 2019. Front Aging Neurosci. 2020. PMID: 31969812 Free PMC article.
-
Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal.Sleep. 2019 Apr 1;42(4):zsz020. doi: 10.1093/sleep/zsz020. Sleep. 2019. PMID: 30715515 Free PMC article.
References
-
- Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine Report. Sleep. 2006;29(11):1415–1419. - PubMed
-
- Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999;281(11):991–999. - PubMed
-
- Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159(1):5–11. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
